Clinical Trials Browser

Phase 2/3 × OTHER × Thyroid Neoplasms × Clear all

NCT06851663 2026-05-29

Trop2-targeted immunoPET Imaging of Solid Tumors

Phase 2/3 Recruiting

GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT01398085 2026-05-07

IoN

Phase 2/3 Active not recruiting

EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT07434206 2026-02-25

Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors

Phase 2/3 Active not recruiting

Thyroid Neoplasms

NCT01083550 2016-11-29

Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer

Phase 2/3 Completed

Thyroid Neoplasms

NCT01137097 2016-04-21

LSLNB

Phase 2/3 Completed

Thyroid Neoplasms

NCT00123760 2016-02-25

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

Phase 2/3 Completed

10,838 enrolled

CNSGastrointestinalHead & NeckLymphoidThoracic

Brain Neoplasms, Lung Neoplasms, Lymphoma, Thyroid Neoplasms, Colorectal Neoplasms

NCT01616316 2012-06-11

Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients

Phase 2/3 Completed

Thyroid Neoplasms